Dianthus Therapeutics, Inc. (DNTH) vs Mirum Pharmaceuticals, Inc. (MIRM)
A side-by-side comparison of Dianthus Therapeutics, Inc. and Mirum Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DNTH
Dianthus Therapeutics, Inc.
$85.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MIRM
Mirum Pharmaceuticals, Inc.
$79.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DNTH vs MIRM
growth of $100 · dividends reinvested · last 7yDNTH -58.7% (-11.9%/yr)MIRM +516.4% (+29.7%/yr)MIRM compounded faster over this window
Log scale — wide-divergence pair
DNTH MIRM
DNTH vs MIRM: by the numbers
- •MIRM is the larger company ($4.83B vs $4.78B market cap).
- •Both run net losses; MIRM's is the smaller (-139.18% vs -1570.85% net margin).
Metrics side by side
Valuation
| Metric | DNTH | MIRM |
|---|---|---|
| P/S ratio | 2508.82 | 7.82 |
| P/B ratio | 4.08 | N/A |
Profitability
| Metric | DNTH | MIRM |
|---|---|---|
| Gross margin | 96.01% | 81.70% |
| Operating margin | -8739.34% | -4.25% |
| Net margin | -1570.85% | -139.18% |
| ROE | -2.55% | N/A |
| ROIC | -18.48% | -13.09% |
Growth (annualized)
| Metric | DNTH | MIRM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 123.86% |
| Total return CAGR (5Y) | -5.50% | 37.24% |
Frequently asked
- How have DNTH and MIRM total returns compared?
- Over the past 5 years, DNTH delivered -5.50% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Dianthus Therapeutics ROEMirum Pharmaceuticals ROEDianthus Therapeutics operating marginMirum Pharmaceuticals operating marginDianthus Therapeutics revenue growthMirum Pharmaceuticals revenue growthDianthus Therapeutics free cash flowMirum Pharmaceuticals free cash flow
Dianthus Therapeutics & Mirum Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.